ЛОСАРДЭКС 50

Երկիր: Իսրայել

Լեզու: ռուսերեն

Աղբյուրը: Ministry of Health

Ակտիվ բաղադրիչ:

LOSARTAN POTASSIUM 50 MG

Հասանելի է:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC կոդը:

C09CA01

Դեղագործական ձեւ:

TABLETS

Կառավարման երթուղին:

PER OS

Պատրաստված է:

DEXCEL LTD

Թերապեւտիկ խումբ:

LOSARTAN

Թերապեւտիկ ցուցումներ:

Hypertension: Losardex is indicated for the treatment of hypertension. Heart failure: Losardex is indicated for the treatment of heart failure (NYHA II and III) usually in addition to diuretics and/or digitalis if use of an ACE inhibitor is not appropriate. Switching patients with heart failure who are stable on an ACE inhibitor to Losardex is not recommended. Renal protection in Type-2 diabetic patients with proteinuria: Losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric

Հաստատման ամսաթիվը:

2013-03-01